| BE0161-50MG
| InVivoMab anti-mouse DR5 (CD262)
| 50 mg
| BioXCell
| in vivo induction TRAIL-mediated apoptosis, in vit
|
| Armenian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0098-50MG
| InVivoMAb recombinant Flt-3L-Ig (hum/hum)
| 50 mg
| BioXCell
|
|
| N/A
| N/
| Solicitar Precio
| Solicitar
|
| BE0091-50MG
| InVivoMab polyclonal Armenian hamster IgG
| 50 mg
| BioXCell
|
|
| Armenian hamster
| N/
| Solicitar Precio
| Solicitar
|
| BE0146-100MG
| InVivoMab anti-mouse PD-1 (CD279)
| 100 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0150-5MG
| InVivoMab anti-mouse CD19
| 5 mg
| BioXCell
| in vivo B cell depletion, in vivo CD19 neutralizat
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0167-5MG
| InVivoMab anti-mouse/rat MHC Class II (I-Ek/RT1-D)
| 5 mg
| BioXCell
| in vivo blocking of antigen presentation, Flow cyt
|
| Mouse
| mouse/ra
| Solicitar Precio
| Solicitar
|
| BE0171-1MG
| InVivoMab anti-mouse TIM-4
| 1 mg
| BioXCell
| in vivo TIM-4 blockade, in vitro TIM-4 blockade, I
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0158-1MG
| InVivoMab anti-mouse MHC Class I (H-2Kk, H-2Dk)
| 1 mg
| BioXCell
| in vivo administration, Flow cytometry
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0101-50MG
| InVivoMab anti-mouse PD-L1 (B7-H1)
| 50 mg
| BioXCell
| in vivo PD-L1 blockade, Immunofluorescence, Immuno
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0175-50MG
| InVivoMab anti-mouse CD71 (TfR1)
| 50 mg
| BioXCell
| in vivo depletion of CD71+ cells
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0159-25MG
| InVivoMab anti-Influenza A virus NP
| 25 mg
| BioXCell
| Immunoprecipitation, Immunohistochemistry (paraffi
|
| Mouse
| Virus
| Solicitar Precio
| Solicitar
|
| BE0183-5MG
| InVivoMab anti-mouse Ter-119
| 5 mg
| BioXCell
| in vivo administration, in vitro erythrocyte negat
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0130-5MG
| InVivoMab polyclonal goat IgG
| 5 mg
| BioXCell
|
|
| Goat
| N/
| Solicitar Precio
| Solicitar
|
| BE0106-50MG
| InVivoMab anti-LCMV nucleoprotein
| 50 mg
| BioXCell
| Immunofluorescence, Flow cytometry
|
| Rat
| LCMV
| Solicitar Precio
| Solicitar
|
| BE0164-5MG
| InVivoMab anti-mouse CTLA-4 (CD152)
| 5 mg
| BioXCell
| in vivo CTLA-4 neutralization
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0120-50MG
| InVivoMab anti-swine MHC Class I (SLAd)
| 50 mg
| BioXCell
| Flow cytometry
|
| Mouse
| Pig
| Solicitar Precio
| Solicitar
|
| BE0130-50MG
| InVivoMab polyclonal goat IgG
| 50 mg
| BioXCell
|
|
| Goat
| N/
| Solicitar Precio
| Solicitar
|
| BE0097-25MG
| InVivoMab recombinant mouse IgG2a Fc
| 25 mg
| BioXCell
|
|
| Mouse
| N/
| Solicitar Precio
| Solicitar
|
| BE0162-25MG
| InVivoMab anti-human Glycophorin A (type M)
| 25 mg
| BioXCell
| in vitro GPA blockade
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0121-100MG
| InVivoMab anti-mouse MHC Class I (H-2Kb)
| 100 mg
| BioXCell
| in vivo administration, Flow cytometry
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0117-100MG
| InVivoMab anti-mouse CD8?
| 100 mg
| BioXCell
| in vivo CD8+ T cell depletion
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0097-1MG
| InVivoMab recombinant mouse IgG2a Fc
| 1 mg
| BioXCell
|
|
| Mouse
| N/
| Solicitar Precio
| Solicitar
|
| BE0182-100MG
| InVivoMab anti-mouse V?8 TCR
| 100 mg
| BioXCell
| Flow cytometry
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0146-25MG
| InVivoMab anti-mouse PD-1 (CD279)
| 25 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0161-1MG
| InVivoMab anti-mouse DR5 (CD262)
| 1 mg
| BioXCell
| in vivo induction TRAIL-mediated apoptosis, in vit
|
| Armenian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0090-5MG
| InVivoMab rat IgG2b isotype control
| 5 mg
| BioXCell
|
|
| Rat
| N/
| Solicitar Precio
| Solicitar
|
| BE0129-1MG
| InVivoMab anti-mouse Notch4
| 1 mg
| BioXCell
| in vitro Notch4 stimulation, in vivo Notch4 blocki
|
| Armenian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0104-1MG
| InVivoMab anti-mouse MHC Class I (H-2Kd)
| 1 mg
| BioXCell
| Purification of MHC peptide complexes, in vivo adm
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0113-5MG
| InVivoMab anti-mouse TIM-1 (CD365)
| 5 mg
| BioXCell
| in vivo TIM-1 neutralization
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0185-100MG
| InVivoMab anti-human/mouse, rat CCL2 (MCP-1)
| 100 mg
| BioXCell
| in vivo CCL2 neutralization, Immunohistochemistry
|
| Armenian hamster
| mouse/human/ra
| Solicitar Precio
| Solicitar
|
| BE0136-5MG
| InVivoMab anti-human E-Selectin
| 5 mg
| BioXCell
| Flow cytometry
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0104-100MG
| InVivoMab anti-mouse MHC Class I (H-2Kd)
| 100 mg
| BioXCell
| Purification of MHC peptide complexes, in vivo adm
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0161-100MG
| InVivoMab anti-mouse DR5 (CD262)
| 100 mg
| BioXCell
| in vivo induction TRAIL-mediated apoptosis, in vit
|
| Armenian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0166-5MG
| InVivoMab anti-mouse V?4 TCR
| 5 mg
| BioXCell
| in vivo administration, Flow cytometry
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0120-1MG
| InVivoMab anti-swine MHC Class I (SLAd)
| 1 mg
| BioXCell
| Flow cytometry
|
| Mouse
| Pig
| Solicitar Precio
| Solicitar
|
| BE0182-5MG
| InVivoMab anti-mouse V?8 TCR
| 5 mg
| BioXCell
| Flow cytometry
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0123-50MG
| InVivoMab anti-human/rat/fish AChR
| 50 mg
| BioXCell
| EAMG induction in rats, Immunofluorescence
|
| Rat
| human/rat/fis
| Solicitar Precio
| Solicitar
|
| BE0090-25MG
| InVivoMab rat IgG2b isotype control
| 25 mg
| BioXCell
|
|
| Rat
| N/
| Solicitar Precio
| Solicitar
|
| BE0144-50MG
| InVivoMab anti-rat FcRn heavy chain heterodimers
| 50 mg
| BioXCell
| ELISA, Flow cytometry
|
| Mouse
| Rat
| Solicitar Precio
| Solicitar
|
| BE0090-1MG
| InVivoMab rat IgG2b isotype control
| 1 mg
| BioXCell
|
|
| Rat
| N/
| Solicitar Precio
| Solicitar
|
| BE0151-50MG
| InVivoMab anti-mouse/human TYRP1/TRP1 (gp75)
| 50 mg
| BioXCell
| in vivo triggering of Fc?Rs, Immunofluorescence, F
|
| Mouse
| mouse/huma
| Solicitar Precio
| Solicitar
|
| BE0121-25MG
| InVivoMab anti-mouse MHC Class I (H-2Kb)
| 25 mg
| BioXCell
| in vivo administration, Flow cytometry
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0113-100MG
| InVivoMab anti-mouse TIM-1 (CD365)
| 100 mg
| BioXCell
| in vivo TIM-1 neutralization
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0155-50MG
| InVivoMab anti-mouse Delta-like protein 1 (DLL1)
| 50 mg
| BioXCell
| in vivo DLL1 neutralization, Flow cytometry
|
| Armenian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0087-100MG
| InVivoMab polyclonal Syrian hamster IgG
| 100 mg
| BioXCell
|
|
| Syrian hamster
| N/
| Solicitar Precio
| Solicitar
|
| BE0117-25MG
| InVivoMab anti-mouse CD8?
| 25 mg
| BioXCell
| in vivo CD8+ T cell depletion
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0131-25MG
| InVivoMab anti-mouse CTLA-4 (CD152)
| 25 mg
| BioXCell
| in vivo CTLA-4 neutralization, in vitro CTLA-4 neu
|
| Syrian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0125-50MG
| InVivoMab anti-mouse Jagged2
| 50 mg
| BioXCell
| in vivo Jagged 2 neutralization
|
| Armenian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0121-5MG
| InVivoMab anti-mouse MHC Class I (H-2Kb)
| 5 mg
| BioXCell
| in vivo administration, Flow cytometry
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0106-5MG
| InVivoMab anti-LCMV nucleoprotein
| 5 mg
| BioXCell
| Immunofluorescence, Flow cytometry
|
| Rat
| LCMV
| Solicitar Precio
| Solicitar
|